INM News and Press, InMed Pharmaceuticals Inc. From 09/19/22

VANCOUVER, British Columbia, Sept. 19, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development and manufacturing of rare cannabinoids, will report financial results on Friday, Se...

InMed Pharmaceuticals (NASDAQ: INM) , a leader in the research, development and manufacturing of rare cannabinoids, has closed on a private placement agreement with two healthcare-focused institutional investors. The agreement consisted of the issue and sale of 691,245 of INM common shares ...

VANCOUVER, British Columbia, Sept. 13, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“ InMed ” or the “ Company ”) ( Nasdaq: INM ), a leader in the research, development and manufacturing of rare cannabinoids, today announced the closing of its...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The relief rally we’ve seen play out last week is once again in full focus on Monday. All major indices have moved higher today. Indeed, investors seem to be taking the view that inflation may have peaked, or is near...

Shares of InMed Pharmaceuticals Inc. (NASDAQ: INM) rose sharply on Monday morning, climbing by 73.96% to $19.17. So far today, approximately 20.65M shares have been exchanged, as compared to an average 30-day volume of 1.21M shares. InMed Pharmaceuticals is a global leader in the develop...

InMed Pharmaceuticals (NASDAQ: INM) , a leader in the research, development and manufacturing of rare cannabinoids, has announced a private placement agreement with two healthcare-focused institutional investors. The agreement calls for the issuance and sale of 691,245 of INM common shares;...

InMed Pharma ( NASDAQ: INM ) said it had entered into a securities purchase agreement with two healthcare-focused institutional investors for the sale of 691,245 of its shares at a purchase price of $8.68 per share, in a private placement priced at-the-market under N...

VANCOUVER, British Columbia, Sept. 09, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“ InMed ” or the “ Company ”) ( Nasdaq: INM ), a leader in the research, development and manufacturing of rare cannabinoids, today announced that it has entere...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Sundry Photography / Shutterstock.com Zscaler (NASDAQ: ZS ) stock is gaining on Friday following the release of the cloud security company’s earnings report for its fiscal fourth quarter of 2022 ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: gvictoria / Shutterstock.com InMed Pharmaceuticals (NASDAQ: INM ) stock is rocketing higher on Friday after the company revealed research and development (R&D) updates . According to the cannabis ...